|
|
||||||||
J Thorac Cardiovasc Surg 2007;133:676-681
© 2007 The American Association for Thoracic Surgery
Surgery for Congenital Heart Disease |
a Department of Pediatrics, Division of Cardiology, The Childrens Hospital of Philadelphia, Philadelphia, Pa
b Department of Pediatrics, Section of Pediatric Cardiology, J.W. Riley Hospital for Children, Philadelphia, Pa.
Received for publication July 31, 2006; revisions received October 4, 2006; accepted for publication October 16, 2006. * Address for reprints: Matthew Harris, MD, Assistant Professor of Pediatrics and Radiology, Divisions of Cardiology and Cardiac MRI, The Childrens Hospital of Philadelphia and the University of Pennsylvania, Office Suite 2205Main Building, Philadelphia, PA 19103 (Email: harrismat{at}email.chop.edu).
| Abstract |
|---|
|
|
|---|
Methods: Seventy-three patients underwent magnetic resonance imaging. Studies were retrospectively reviewed for the presence of delayed enhancement along the ventricular outflow tracts, cardiac valves, and where available, the ascending aorta. Three groups were identified. Group A patients (n = 34) underwent right ventricular outflow tract reconstruction and ventricular septal defect patch closure. Group B patients (n = 33) had never undergone cardiac surgery. Group C patients (n = 6) had functional single ventricle and underwent Norwood reconstruction.
Results: In group A, 31 of 34 patients had delayed enhancement of the right ventricular outflow tract, and 14 of 34 had delayed enhancement of the ventricular septal defect patch (P < .001). In group B (n = 33), 1 patient with arrhythmogenic right ventricular dysplasia had delayed enhancement limited to the right ventricular outflow tract. The remainder had no delayed enhancement of either outflow tract. Delayed enhancement of the aortic valve and ascending aorta was observed in 13 of 34 (P = .002) and 10 of 26 (P = .05) group A patients, respectively, compared with 2 of 33 and 3 of 24 group B patients. In group C, delayed enhancement of the Norwood reconstruction was observed in 5 of 6 patients (P = .002).
Conclusions: Delayed-enhancement imaging detects fibrous tissue along regions of reconstruction in patients who have had surgery for congenital heart disease. Furthermore, delayed-enhancement imaging detects fibrous tissue in regions not directly related to the reconstructive surgery, including cardiac valves and the wall of the ascending aorta.
| Introduction |
|---|
|
|
|---|
|
Patients with congenital heart defects such as tetralogy of Fallot (TOF) may require surgical intervention involving reconstruction of the right ventricular outflow tract (RVOT) and patch closure of a ventricular septal defect (VSD). Reconstruction of the RVOT is typically performed with cryopreserved homograft tissue as a transannular patch or a valved conduit.1,2
VSD patches are most commonly composed of artificial materials such as polytetrafluoroethylene or Dacron.2,3
Histologic evidence of fibrous tissue formation has been observed on the surface of homograft and artificial patch material in animal models4,5
and humans.6,7
Delayed-enhancement (DE) magnetic resonance (MR) imaging can identify myocardial fibrosis.8-11
DE occurs after intravenous administration of a gadolinium chelate, which primarily remains in the interstitial space. The proposed mechanisms involve delayed contrast washout and an increased volume of distribution present in fibrous tissue.12-14
We hypothesized that DE should occur in regions directly associated with the surgical reconstruction where fibrous tissue formation occurs. Recently, DE of the RVOT and in the region of VSD repair was reported in adults with TOF.15,16
Our study differs in that it specifically investigated the pediatric population, in whom fibrous tissue may not have had the time to form. In addition, fibrous tissue formation in children may affect the surgical reconstruction differently than in adults, because the patients and their hearts continue to grow. Moreover, recent studies have shown that fibrous tissue is found within the aortic sinuses and the wall of the ascending aorta in patients with TOF, providing a possible mechanism for TOF aortopathy.17
Therefore, we expanded our DE MR study to determine whether fibrous tissue could be identified in regions not directly involved in the reconstructive surgical repair, such as in heart valves and within the wall of the ascending aorta. Finally, in this study, we confirmed our findings using a control population of patients who had never undergone cardiovascular surgery.
| Materials and Methods |
|---|
|
|
|---|
|
|
|
Patients under 7 years of age were typically sedated for the MR study with pentobarbital, and midazolam, except for infants under age 1, who received chloral hydrate. No complications were observed.
Approximately 10 minutes after the administration of gadopentetate dimeglumine, (0.4 mmol/kg), and with the appropriate inversion time to achieve myocardial nulling, DE imaging was executed in the same long- and short-axis planes that were used for cine imaging. Comparison of the cine and DE images distinguished DE from other potential causes of bright signal, such as pericardial fat or fluid. DE studies consisted of steady-state free precession (SSFP) or fast low-angle shot (FLASH) inversion recovery sequence with and without phase-sensitive inversion recovery. Typical SSFP parameters were repetition time 10% of R-R interval, echo time 1.3 ms, inversion time 300 ms, flip angle 45°, segments 65, and voxel size 1.8 x 1.3 x 8.0 mm. Typical FLASH parameters were repetition time 10% of R-R interval, echo time 4.4 ms, inversion time 260 ms, flip angle 30°, segments 25, and voxel size 1.7 x 1.3 x 8.0 mm. Infant studies included single-shot acquisition, two averages, and thinner slices (5.06.0 mm). Group A studies were reviewed for the presence or absence of DE of the RVOT patch/conduit, VSD patch, valve leaflets, and where available, the ascending aorta. Group B studies served as controls. Group C studies were reviewed for DE of the aortic reconstruction.
Statistical Analysis
Data are expressed as mean and SD range as appropriate. The Fisher exact test was performed as appropriate.
| Results |
|---|
|
|
|---|
|
|
|
|
|
DE of the Ascending Aorta
DE of the ascending aorta was observed in 10 (38%) of 26 group A patients and 3 (13%) of 24 group B patients (P = .03) (Figure 3; Table 4). The ascending aorta was not observed in 8 group A patients and 9 group B patients.
DE of Homograft Reconstruction of the Aorta
Five (83%) of 6 Norwood reconstructions compared with 3 (13%) of 24 group B patients showed DE (P = .002).
Structurally Abnormal Valves
In group A, 2 of the 5 patients with truncus arteriosus had DE of the truncal valve (Figure 1). In group B, there were 7 patients with bicuspid aortic valve. Of these, only 1 (14%) exhibited DE of the aortic valve and the ascending aorta. The remaining 6 had no DE of either the aortic valve or the ascending aorta. In group B, there was 1 patient with Ebstein anomaly who showed DE of the septal leaflet of the tricuspid valve (Figure E1, A, and E1, B).
|
| Discussion |
|---|
|
|
|---|
We studied younger patients to stress that fibrous tissue deposition is significant enough to image even among infants, children, and young adults. During these early postoperative years, patients generally do not exhibit right ventricular dysfunction from chronic valvular or conduit incompetence and the resultant volume overload. Our findings of frequent DE along RVOT reconstructions (31/34, 91%) occur in the context of a preserved mean right ventricular ejection fraction (61% ± 9%). This is in contrast to the adult TOF patient studies,15,16
which reported significantly lower right ventricular ejection fractions in the populations that had DE. The differences in right ventricular function between the two studies suggest that the impact of DE differs between the pediatric and adult populations.
Identifying fibrous material in the pediatric context may be important, because the fibrosis may contribute to RVOT obstruction in the form of a fibrous peel within a conduit. Nearly half of our surgically treated patients had at least qualitatively moderate-range conduit stenosis. Conduit obstruction is not an uncommon finding in the pediatric population because patients outgrow conduits placed in infancy.
It is unclear why DE of the RVOT homograft reconstruction was more common than DE of the artificial VSD patch (91% vs 41%). It is possible that the original homograft collagenous skeleton provides the framework for fibrous tissue deposition through immune-mediated responses of the host to the donor tissue endothelial surface proteins, as has been postulated for cryopreserved homograft valve implant failure.7
Similar to RVOT homograft patch reconstructions, it is understandable that DE of Norwood homograft reconstructions is common when compared with normal aortas.
Interestingly, we observed that even structures not directly involved in the surgical repair may exhibit DE. For instance, patients with repaired conotruncal anomalies without homograft reconstruction of the ascending aorta exhibited DE of the ascending aorta more frequently than the control population (41% vs 13%; P = .05). DE of the aortic wall unrelated to surgical reconstruction has been reported in Takayasu arteritis,18
which is thought to result from aortic wall inflammation. Furthermore, DE of the aortic valve occurred more commonly in the group with repaired conotruncal anomalies than in the control group (37% vs 6%; P < .01). Dilation of the aortic root and ascending aorta frequently occurs in patients with TOF. Recently, the histologic basis of TOF aortopathy in infants and adults was described by Tan and associates.17
The findings included fibrosis, cystic medial necrosis, elastic fragmentation, and elastic lamellae disruption involving the aorta and the aortic sinuses. We speculate that these abnormal histologic findings could result in impaired gadolinium washout kinetics and provide a possible explanation for our observation of DE of aortas and aortic valve cusps in patients with conotruncal anomalies. Tan and colleagues17
also found earlier onset of elastin fragmentation and elastin lamellae disruption of the aortic root and ascending aorta in patients with TOF in contrast to those with a bicuspid aortic valve. Although not statistically significant, we found a trend among our pediatric study population showing that patients with repaired conotruncal anomalies exhibited DE of the aortic valve (14/34) and ascending aorta (10/26) more often than do patients with a bicuspid aortic valve (1/7). Nevertheless, it is possible that the fibrous tissue identified in the ascending aorta could be related to a previous cannulation site or aortic crossclamping. However, the degree of DE observed was diffuse and not discrete and, therefore, would less likely be thought to result from aortic cannulation or crossclamping. Finally, though it had not previously been reported, we are reassured that our findings of DE of valve tissue are valid, inasmuch as it is present on DE images performed at other institutions.19
Though metabolically active, cardiac valves have been thought to be relatively avascular structures, possessing few capillaries proximally, receiving their blood supply primarily via diffusion.20
Weind, Ellis, and Boughner21
demonstrated the existence of a more extensive vasculature than previously thought in the aortic valve of swine and suggested that cryopreserved homograft implants fail owing to the absence of this functioning vasculature. It is interesting that in our study atrioventricular valves exhibit DE more frequently than aortic valves, in both the repaired conotruncal and control groups. Though the reason for this finding is unclear, it suggests that different contrast washout kinetics operate between atrioventricular and semilunar valves. It is also interesting that the tricuspid valve was frequently enhanced in both the surgical and control groups (74% vs 52%), without statistical difference. Inasmuch as the DE was not confined to the septal leaflet of the tricuspid valve, one can reasonably consider that tricuspid valve DE is a property of its contrast washout kinetics and not the result of VSD closure.
| Study Limitations |
|---|
|
|
|---|
| Conclusions |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
K. G. Ordovas and C. B. Higgins Delayed Contrast Enhancement on MR Images of Myocardium: Past, Present, Future Radiology, November 1, 2011; 261(2): 358 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rickers, I. Voges, M. Jerosch-Herold, J. Hedderich, C. Westphal, C. Hart, M. Helle, J. Scheewe, E. Pardun, and H.-H. Kramer Response to Letter Regarding Article, "Maladaptive Aortic Properties in Children After Palliation of Hypoplastic Left Heart Syndrome Assessed by Cardiovascular Magnetic Resonance Imaging" Circulation, May 17, 2011; 123(19): e595 - e595. [Full Text] [PDF] |
||||
![]() |
G. Di Bella, F. Minutoli, A. Mazzeo, G. Vita, G. Oreto, S. Carerj, C. Anfuso, M. Russo, and M. Gaeta MRI of Cardiac Involvement in Transthyretin Familial Amyloid Polyneuropathy Am. J. Roentgenol., December 1, 2010; 195(6): W394 - W399. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Voges, M. Jerosch-Herold, J. Hedderich, C. Westphal, C. Hart, M. Helle, J. Scheewe, E. Pardun, H.-H. Kramer, and C. Rickers Maladaptive Aortic Properties in Children After Palliation of Hypoplastic Left Heart Syndrome Assessed by Cardiovascular Magnetic Resonance Imaging Circulation, September 14, 2010; 122(11): 1068 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nazarian, D. A. Bluemke, and H. R. Halperin Applications of Cardiac Magnetic Resonance in Electrophysiology Circ Arrhythm Electrophysiol, February 1, 2009; 2(1): 63 - 71. [Full Text] [PDF] |
||||
![]() |
R. J. Gibbons, P. A. Araoz, and E. E. Williamson The Year in Cardiac Imaging J. Am. Coll. Cardiol., September 4, 2007; 50(10): 988 - 1003. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |